Intravenous immunoglobulin treatment of children immune thrombocytopenia Meta analysis of efficacy and safety in CHINA

被引：0
|
作者：
He, Z. [1 ]
Li, T. [1 ]
Shu, L. [1 ]
机构：
[1] Guiyang Med Coll, Affiliated Hosp, Dept Paediat, Guiyang, Peoples R China
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO321-WED
引用
收藏
页码：869 / 869
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of a new intravenous immunoglobulin (Panzyga®) in chronic immune thrombocytopenia
    Arbach, O.
    Taumberger, A. B.
    Wietek, S.
    Cervinek, L.
    Salama, A.
    TRANSFUSION MEDICINE, 2019, 29 (01) : 48 - 54
  • [2] SAFETY OF INTRAVENOUS IMMUNOGLOBULIN FOR TREATMENT OF AUTOIMMUNE THROMBOCYTOPENIA
    GUTTERIDGE, CN
    VEYS, P
    NEWLAND, AC
    ACTA HAEMATOLOGICA, 1988, 79 (02) : 88 - 90
  • [3] Identification of predictive factors for response to intravenous immunoglobulin treatment in children with immune thrombocytopenia
    Yoshihito Morimoto
    Nao Yoshida
    Nozomu Kawashima
    Kimikazu Matsumoto
    Koji Kato
    International Journal of Hematology, 2014, 99 : 597 - 602
  • [4] Identification of predictive factors for response to intravenous immunoglobulin treatment in children with immune thrombocytopenia
    Morimoto, Yoshihito
    Yoshida, Nao
    Kawashima, Nozomu
    Matsumoto, Kimikazu
    Kato, Koji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (05) : 597 - 602
  • [5] Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia
    Crow, Andrew R.
    Song, Seng
    Siragam, Vinayakumar
    Lazarus, Alan H.
    PEDIATRIC BLOOD & CANCER, 2006, 47 (05) : 710 - 713
  • [6] Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP)
    Hong, Junshik
    Bang, Soo-Mee
    Mun, Yeung-Chul
    Yhim, Ho-Young
    Lee, Jaehoon
    Lim, Hyeong-Seok
    Oh, Doyeun
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (19)
  • [7] Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam® 10%) in patients with immune thrombocytopenia
    Robak, Tadeusz
    Mainau, Claudia
    Pyringer, Barbara
    Chojnowski, Krzysztof
    Warzocha, Krzysztof
    Dmoszynska, Anna
    Straub, Jan
    Imbach, Paul
    HEMATOLOGY, 2010, 15 (05) : 351 - 359
  • [8] The treatment of idiopathic thrombocytopenic purpura in adults: The efficacy of domestic intravenous immunoglobulin in immune thrombocytopenia
    Pugina, SA
    Evdokimova, NM
    Rastorguev, GG
    Samoilova, OS
    Sorokina, IV
    Sidnev, GV
    Vasilyev, DM
    Anastasiev, VV
    Milovidova, OV
    Molodovskaya, EV
    Borovkov, NN
    TERAPEVTICHESKII ARKHIV, 1999, 71 (08) : 50 - 54
  • [9] Can low-dose intravenous immunoglobulin be an alternative to high-dose intravenous immunoglobulin in the treatment of children with newly diagnosed immune thrombocytopenia: a systematic review and meta-analysis
    Ren, Xiangge
    Zhang, Miaomiao
    Zhang, Xiaohan
    Zhao, Peidong
    Zhai, Wensheng
    BMC PEDIATRICS, 2024, 24 (01)
  • [10] Efficacy and safety of eltrombopag in the treatment of Chinese children with chronic immune thrombocytopenia
    Chen, Mo
    Fang, Jian-Pei
    Zhou, Chuan-Xin
    Li, Xin-Yu
    Lin, Shao-Fen
    Xu, Lu-Hong
    HEMATOLOGY, 2021, 26 (01) : 31 - 36
12345